Glaucoma Clinical Trials in Raleigh, NC

Glaucoma Clinical Trials in Raleigh, NC

View the best 10 glaucoma medical studies in Raleigh, North Carolina. Access promising new therapies by applying to a Raleigh-based Glaucoma clinical trial.

Trials in Raleigh, North Carolina

Here are the top 5 medical studies for glaucoma in Raleigh, North Carolina

Image of Duke Eye Center in Durham, United States.

Medical grade acrylic tip coated with medical grade silicone of a thickness < 100 µm

Recruiting1 award1 criteria
This trial aims to compare the comfort and tolerance of 3 new anesthesia-free tonometer tips with the standard tip used with anesthesia. The goal is to find the most comfortable prototype tip for home use.
Image of Duke Eye Center in Durham, United States.

Yutiq 0.18 MG Drug Implant

Recruiting3 awardsPhase < 1
This trial tests a small device that releases a steroid into the eye during glaucoma surgery to reduce scarring and control eye pressure. It targets patients having glaucoma or combined glaucoma and cataract surgery. The steroid helps reduce inflammation, aiming for better post-surgery outcomes.
Image of Sacramento Eye Consultants, A Medical Corporation in Sacramento, United States.

Monofocal IOL +2 More

Intraocular Lens

Recruiting1 award5 criteria
This trial is evaluating the placement and effects of a tiny device called the Hydrus Microstent in patients having cataract surgery. The device helps drain fluid from the eye to reduce pressure. The study will monitor patients over time to see how well the device works and if there are any issues. The Hydrus Microstent is designed to increase fluid drainage from the eye and lower eye pressure.
Image of Eye Research Foundation in Newport Beach, United States.

NCX 470 0.1% +1 More

Prostaglandin Analog

Recruiting2 awardsPhase 3
This trial is testing NCX 470 eye drops to see if they can safely and effectively lower eye pressure in people with high eye pressure or glaucoma. The goal is to protect their vision by reducing the pressure inside their eyes. NCX 470 is a nitric oxide (NO)-donating bimatoprost with clinically demonstrated pressure-lowering effects.
Image of United Medical Research Institute in Inglewood, United States.

Latanoprost +2 More

Prostaglandin Analogues

Recruiting0 awardsPhase 2
"This trial aims to test the safety and effectiveness of two different eye drops in people with open-angle glaucoma or high eye pressure."

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.